Skip to main content
SpringerLink
Log in

Changes in the serotonin transporter in the hippocampus of subjects with schizophrenia identified using [3H]paroxetine

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

[3H]paroxetine binding to membrane from hippocampus, obtained at autopsy, from 24 schizophrenic and 24 non-schizophrenic subjects has been measured. The affinity of [3H]paroxetine binding to hippocampal membrane was decreased in subjects with schizophrenia (Kd=0.50 ± 0.04 vs. 0.24 ± 0.02nM; mean ± S.E.M. p < 0.001) but was not different in schizophrenic subjects who had or had not committed suicide (Kd=0.50 ± 0.07 vs. 0.50 ± 0.04nM). The density of [3H]paroxetine binding sites did not differ between the schizophrenic and non-schizophrenic subjects. For the schizophrenic subjects, there was no relationship between ante-mortem neuroleptic drug treatment and [3H]paroxetine binding to the hippocampal membrane. Finally, this study has shown that neuroleptic drug treatment of rats does not alter [3H]paroxetine binding to the hippocampal membranes. Thus, it would seem that the changes in the affinity of [3H]paroxetine binding to the hippocampus of schizophrenic subjects are not likely to be due to neuroleptic drug treatment but may be involved in the pathology of the illness.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Andersson A, Sundman I, Marcusson J (1992) Age stability of human brain 5-HT terminals studied with [3H]paroxetine binding. Gerontology 38: 127–132

    PubMed  Google Scholar 

  • Arora RC, Meltzer HY (1991) Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients. J Neural Transm [Gen Sect] 85: 19–29

    Google Scholar 

  • Bennett JP, Enna SJ, Byland DB, Gillin JC, Wyatt RJ, Snyder SH (1979) Neurotransmitter receptors in frontal cortex of schizophrenics. Arch Gen Psychiatry 36: 927–934

    PubMed  Google Scholar 

  • Dean B, Opeskin K, Pavey G, Naylor L, Hill C, Keks N, Copolov DL (1995) [3H]Paroxetine binding is altered in the hippocampus but not the frontal cortex or caudate nucleus from subjects with schizophrenia. J Neurochem 64: 1197–1202

    PubMed  Google Scholar 

  • Habert E, Graham D, Tahraoui L, Claustre Y, Langer S (1985) Characterization of [3H]paroxetine binding to rat cortical membrane. Eur J Pharmacol 118: 107–114

    PubMed  Google Scholar 

  • Hashimoto T, Kitamura N, Kajimoto Y, Shirai Y, Shirakawa O, Mita T, Nishino N, Tanaka C (1993) Differential changes in serotonin 5-HT1A and 5-HT2 receptor binding in patients with chronic schizophrenia. Psychopharmacology 112: 35–39

    Google Scholar 

  • Joyce JN, Shane A, Lexow N, Winokur A, Casanova MF, Kleinman JE (1994) Serotonin uptake sites and serotonin receptors are altered in limbic system of schizophrenics. Neuropsychopharmacology 8: 315–336

    Google Scholar 

  • Kerwin RW (1994) The new atypical antipsychotics. Br J Psychiatry 164: 141–148

    PubMed  Google Scholar 

  • Laruelle M, Abi-Dargham A, Casanova MF, Toti R, Weinberger DR, Kleiman JF (1993) Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. Arch Gen Psychiatry 50: 810–818

    PubMed  Google Scholar 

  • Lesen KP, Wolozin BL, Murphy DL, Riederer P (1993) Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem 60: 2319–2322

    PubMed  Google Scholar 

  • Maguire K, Tuckwell V, Pereira A, Dean B, Singh B (1993) Significant correlation between14C-5-HT uptake by and3H-paroxetine binding to platelets from healthy volunteers. Biol Psychiatry 34: 356–360

    PubMed  Google Scholar 

  • Marcusson JO, Backstrom I, Ross SB (1988) Characterization of [3H]paroxetine binding in rat brain. J Neurochem 50: 1783–1790

    PubMed  Google Scholar 

  • Mellerup ET, Plenge P (1986) High affinity binding of3H-paroxetine and3H-imipramine to rat neuronal membranes. Psychopharmacol 89: 436–439

    PubMed  Google Scholar 

  • Mita T, Hanada S, Nishino N, Kuno T, Nakai H, Yamadori T, Mizoi Y, Tanaka C (1986) Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics. Biol Psychiatry 21: 1407–1414

    PubMed  Google Scholar 

  • Plenge P, Mellerup ET (1985) Antidepressive drugs can change the affinity of [3H]imipramine and [3H]paroxetine binding to platelet and neuronal membranes. Eur J Pharmacol 119: 1–8

    PubMed  Google Scholar 

Download references

Author information

Author notes

  1. L. Naylor

    Present address: The Rebecca L. Cooper Laboratories, The Mental Health Research Institute of Victoria, USA

Authors and Affiliations

  1. The Rebecca L. Cooper Laboratories, The Mental Health Research Institute of Victoria, USA

    B. Dean, K. Opeskin, G. Pavey, C. Hill, N. Keks & D. Copolov

  2. The NH & MRC Schizophrenia Research Unit, Royal Park Psychiatric Hospital, Parkville, Victoria

    L. Naylor, B. Dean & D. Copolov

  3. The Victorian Institute of Forensic Pathology, South Melbourne, Victoria

    K. Opeskin

  4. The Department of Psychiatry, The Alfred Hospital, Commercial Road, Prahran, Victoria, Australia

    N. Keks

Authors
  1. L. Naylor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Dean
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Opeskin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Pavey
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Hill
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N. Keks
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D. Copolov
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Naylor, L., Dean, B., Opeskin, K. et al. Changes in the serotonin transporter in the hippocampus of subjects with schizophrenia identified using [3H]paroxetine. J. Neural Transmission 103, 749–757 (1996). https://doi.org/10.1007/BF01271234

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01271234

Keywords

Search

Navigation